You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

  1. On Site Mercury Remediation via Activated Fly Ash

    SBC: POLLUTION CONTROL TECHNOLOGIES, LLC            Topic: NIEHS

    DESCRIPTION provided by applicant Mercury is one of the most harmful and toxic pollutants to humans and it is predominantly introduced into the environment in vapor form from burning fossil fuels Fossil fuel consumption results in ever higher mercury concentrations in the air water soil and ultimately in food that humans consume The EPA estimates that mercury instigated healthcare costs ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Scalable amperometric microchip array for high throughput screening of small molecules peptides or genetic perturbations for modulation of quantal transmitter release

    SBC: EXOCYTRONICS, LLC            Topic: 101

    ` The goal of this project is the development of a scalable n x m electrochemical detector array platform with on chip amplifiers for massively parallel recordings of quantal transmitter release events The neurobiological process that this assay analyzes is the process of exocytosis and transmitter release Neurotransmitters and hormones are stored at high concentration in membrane bound organel ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery

    SBC: Intact Genomics Inc.            Topic: NIAID

    PROJECT SUMMARY According to a CDC report antibiotic resistant infections are associated with deaths and million illnesses in the United States each year The estimated annual impact of antibiotic resistant infections on the national economy is $ billion in excess direct health care costs and in lost productivity from hospitalizations and sick days The emergence of drug resistant mic ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Glycoengineered insect cells for commercial biologics manufacturing

    SBC: Glycobac, LLC            Topic: 300

    DESCRIPTION provided by applicant Therapeutic proteins or andapos biologicsandapos represent a andgt $ billion market that includes a variety of important drugs such as antibodies and hormones The clinical efficacy of many biologics is determined by their sugar structures or andapos glycansandapos Most biologics are manufactured in mammalian cells because they add human type glycans ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. A Search Engine for Heterogeneous Information Needs in the Clinical Workflow

    SBC: MEDSOCKET OF MISSOURI, INC.            Topic: NLM

    DESCRIPTION provided by applicant Modern clinical practices represent a prototypical information intensive distributed and collaborative environment where physicians struggle to find the right information at the right time to make effective clinical decisions The situation is exacerbated not only by federal guidelines and policies regarding compliance to clinical quality metrics and meaningf ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Human Apyrase Therapy for Acute Ischemic Stroke

    SBC: APT THERAPEUTICS, INC.            Topic: 105

    Principal Investigator Program Director Last First Middle Chen Ridong Abstract There remains a crucial unmet medical need in acute ischemic stroke AIS treatment Approximately of patients die within one year and are permanently disabled making AIS the fourth leading cause of death and the leading cause of adult disability in the USA with an estimated cost range of $ ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  7. A FLUOROMETRIC SENSOR FOR Cr(VI)

    SBC: MARKTEK INC            Topic: N/A

    Hexavalent chromium, Cr(VI), in the usual form of oxo species, is used in manyindustrial processes and products. As a consequence, Cr(VI)= containingcompounds are often found in wastewater and contaminated sites. Since Cr(VI) isconsidered highly toxic and carcinogenic, it is extremely important to have areliable, easy-to-use, sensitive monitor for determining Cr(VI) concentrationsin process, on ...

    SBIR Phase I 1995 Environmental Protection Agency
US Flag An Official Website of the United States Government